National Guideline Clearinghouse | Thalidomide in multiple myeloma.

Guideline Title
Thalidomide in multiple myeloma.

Bibliographic Source(s)
Hicks LK, Haynes AE, Reece DE, Walker I, Herst JA, Meyer RM, Imrie K, Hematology Disease Site Group. Thalidomide in multiple myeloma. Toronto (ON): Cancer Care Ontario (CCO); 2010 Jan 20. 71 p. (Evidence-based series; no. 6-21). [96 references]

Guideline Status
This is the current release of the guideline.

The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities.

Please visit the Cancer Care Ontario Web site for details on any new evidence that has emerged and implications to the guidelines.

Thalidomide in multiple myeloma
http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=63148


full-text:
National Guideline Clearinghouse | Thalidomide in multiple myeloma.